ES418113A1 - Piperazino-pyrimidines process for their preparation and use - Google Patents
Piperazino-pyrimidines process for their preparation and useInfo
- Publication number
- ES418113A1 ES418113A1 ES418113A ES418113A ES418113A1 ES 418113 A1 ES418113 A1 ES 418113A1 ES 418113 A ES418113 A ES 418113A ES 418113 A ES418113 A ES 418113A ES 418113 A1 ES418113 A1 ES 418113A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- pyrimidine
- group
- preparation
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
A procedure for the preparation of pyrimidine derivatives of the general formula: **(See formula)** where R represents a methyl or methylthio group, X represents a halogen atom or an alkoxy group of 1 to 5 carbon atoms, Y represents an optionally substituted acylamino or amino group, Z represents a hydrogen atom or a methyl, ethyl group, hydroxyethyl or phenyl, except for 2-methylamino-4-N-methylpiperazino-5-methylthio-6-chloro-pyrimidine, whose procedure is characterized by reacting a 4,6-dichloro-pyrimidine of formula: **(See formula)** with a piperazine of the formula: **(See formula)** in an anhydrous medium, in the presence of an acid accepting agent, at a temperature comprised between 40 and 120ºC and, if necessary, replace the chlorine atom of the product obtained with an alkoxy group. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7324874A FR2257294B1 (en) | 1973-07-06 | 1973-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES418113A1 true ES418113A1 (en) | 1976-03-16 |
Family
ID=9122191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES418113A Expired ES418113A1 (en) | 1973-07-06 | 1973-08-22 | Piperazino-pyrimidines process for their preparation and use |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5849548B2 (en) |
BE (1) | BE803803A (en) |
CH (1) | CH582171A5 (en) |
DE (1) | DE2342880A1 (en) |
ES (1) | ES418113A1 (en) |
FR (1) | FR2257294B1 (en) |
GB (1) | GB1434544A (en) |
LU (1) | LU68263A1 (en) |
MX (1) | MX2978E (en) |
NO (1) | NO137205C (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7605319A (en) * | 1975-05-23 | 1976-11-25 | Mar Pha Etu Expl Marques | PROCESS FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCESS FOR PREPARING SUITABLE MEDICINAL COMPOUNDS. |
FR2417507A2 (en) * | 1977-07-28 | 1979-09-14 | Ugine Kuhlmann | DIAMINO-2,4 (OR -4,6) METHYLTHIO-5 PYRIMIDINES HERBICIDES |
JPS54159877A (en) * | 1978-06-07 | 1979-12-18 | Matsushita Electronics Corp | Detection method for semiconductor substrate position and break |
FR2503162A1 (en) * | 1981-04-07 | 1982-10-08 | Pharmindustrie | NOVEL PIPERAZINO-2 PYRIMIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS OR AS INTERMEDIATES FOR THE PRODUCTION OF MEDICAMENTS |
JPS6177335A (en) * | 1984-09-25 | 1986-04-19 | Kazumichi Kimura | Defective mark detector for semiconductor pellet |
IT1191845B (en) * | 1986-01-20 | 1988-03-23 | Dompe Farmaceutici Spa | PHARMACOLOGICALLY ACTIVE ALCHYLOLS |
JPH02114936U (en) * | 1989-03-03 | 1990-09-14 |
-
1973
- 1973-07-06 FR FR7324874A patent/FR2257294B1/fr not_active Expired
- 1973-08-16 NO NO3260/73A patent/NO137205C/en unknown
- 1973-08-20 BE BE134751A patent/BE803803A/en not_active IP Right Cessation
- 1973-08-20 LU LU68263A patent/LU68263A1/xx unknown
- 1973-08-22 ES ES418113A patent/ES418113A1/en not_active Expired
- 1973-08-23 CH CH1213673A patent/CH582171A5/xx not_active IP Right Cessation
- 1973-08-24 DE DE19732342880 patent/DE2342880A1/en not_active Ceased
- 1973-09-06 JP JP48100728A patent/JPS5849548B2/en not_active Expired
- 1973-09-12 GB GB4286673A patent/GB1434544A/en not_active Expired
- 1973-11-08 MX MX003804U patent/MX2978E/en unknown
Also Published As
Publication number | Publication date |
---|---|
LU68263A1 (en) | 1973-10-24 |
MX2978E (en) | 1980-01-17 |
NO326073L (en) | 1975-02-03 |
FR2257294B1 (en) | 1977-07-01 |
DE2342880A1 (en) | 1975-01-30 |
NO137205C (en) | 1978-01-18 |
NO137205B (en) | 1977-10-10 |
BE803803A (en) | 1974-02-20 |
GB1434544A (en) | 1976-05-05 |
JPS5025578A (en) | 1975-03-18 |
CH582171A5 (en) | 1976-11-30 |
FR2257294A1 (en) | 1975-08-08 |
JPS5849548B2 (en) | 1983-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES467288A1 (en) | N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidineacetamides | |
ES391299A1 (en) | 2-(n-allyl-phenylamino)-imidazolines-(2)and salts thereof | |
ES417333A1 (en) | Omega-(4'-(3"-indolyl)-piperidino)-alkyl-arylketones | |
ES418113A1 (en) | Piperazino-pyrimidines process for their preparation and use | |
ES442845A2 (en) | Novel derivatives of N-(3,4,5-trimethoxy cinnamoyl)piperazine and the process for preparing them | |
GB866843A (en) | Sulphonamidopyrimidines | |
ES448721A1 (en) | A procedure for the production of antibacterial amidic compounds. (Machine-translation by Google Translate, not legally binding) | |
ES440030A1 (en) | 2-aminoindane derivatives | |
ES450380A1 (en) | Indaneacetic acid derivatives | |
ES389360A1 (en) | Aryloxy-and arylthioalkanoic acids and esters and salts thereof | |
ES423104A1 (en) | Procedure for preparing heterociclic anilides. (Machine-translation by Google Translate, not legally binding) | |
ES436624A1 (en) | Pyrimidones | |
ES440153A2 (en) | Piperazinopyrimidines process for their preparation and use | |
ES437803A1 (en) | Novel thiophene derivatives and their preparation | |
GB1451477A (en) | Phenylamidinourea derivatives processes for their preparation and compositions incorporating them | |
ES435351A1 (en) | 1-(3-phenylpropyl)-4-furoylpiperazine derivatives | |
ES419450A1 (en) | Exchange amination process | |
ES389161A1 (en) | Formamidine derivatives and the composition containing same | |
GB1501795A (en) | Phenylsulphonyl formamidine derivatives and their preparation and use | |
ES425533A1 (en) | Dichlorothiazolylureas processes for their preparation and their use as herbicides | |
ES401342A1 (en) | Pyridine derivatives | |
ES301710A1 (en) | Procedure for the preparation of new 1,2-diaril-4-alkyl-3,5-dioxo-pirazolidines (Machine-translation by Google Translate, not legally binding) | |
ES387840A1 (en) | 2-(2-imidazolin-2-ylthio)-acetanilides | |
ES411445A1 (en) | Procedure for the preparation of 4,6-dichloro-pirazolo- (3,4-d) -pirimidine or its derivatives. (Machine-translation by Google Translate, not legally binding) | |
GB877106A (en) | Substituted urea complex salts |